The truth about donanemab, lecanemab and the new class of Alzheimer’s drugs | New Scientist

Three drugs approved for Alzheimer’s disease have been hailed as a breakthrough in treating the condition – how effective are they, and what risks and side effects do they come with?

The truth about the new class of Alzheimer’s drugs
Three drugs approved for Alzheimer’s disease have been hailed as a breakthrough in treating the condition – how effective are they, and what risks and side effects do they come with?


22   1
www.newscientist.com View






Load more